Patrice Hildgen
- Biomaterials top 0.5%
- Molecular Biology top 10%
- Biomedical Engineering top 5%
- Pharmaceutical Science top 0.5%
- Organic Chemistry top 5%
- Co-authors
- Jean‐Michel RabanelXavier BanquyRenu Singh DhanikulaGrégoire LeclairAnteneh ArgawJean‐François BouchardShilpa SantJean‐Christophe Leroux
- Topics
- Nanoparticle-Based Drug Delivery (23 papers)Advanced Drug Delivery Systems (21 papers)RNA Interference and Gene Delivery (11 papers)
- Partner nations
- CanadaFranceUnited Kingdom
In The Last Decade
Patrice Hildgen
76 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 140
- Biomaterials 1.3k
- Molecular Biology 831
- Biomedical Engineering 703
- Pharmaceutical Science 698
- Organic Chemistry 358
Countries citing papers authored by Patrice Hildgen
This map shows the geographic impact of Patrice Hildgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrice Hildgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrice Hildgen more than expected).
Fields of papers citing papers by Patrice Hildgen
This network shows the impact of papers produced by Patrice Hildgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrice Hildgen. The network helps show where Patrice Hildgen may publish in the future.
Co-authorship network of co-authors of Patrice Hildgen
This figure shows the co-authorship network connecting the top 25 collaborators of Patrice Hildgen. A scholar is included among the top collaborators of Patrice Hildgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrice Hildgen. Patrice Hildgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 60 | |
| 2 | 22 | |
| 3 | 35 | |
| 4 | 20 | |
| 5 | 44 | |
| 6 | Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions | 1 |
| 7 | 19 | |
| 8 | 15 | |
| 9 | 108 | |
| 10 | 78 | |
| 11 | 2 | |
| 12 | 29 | |
| 13 | 7 | |
| 14 | 15 | |
| 15 | 16 | |
| 16 | 22 | |
| 17 | 107 | |
| 18 | 15 | |
| 19 | 62 | |
| 20 | 18 |
About Patrice Hildgen
Patrice Hildgen is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 76 papers that have together received 2.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (23 papers), Advanced Drug Delivery Systems (21 papers) and RNA Interference and Gene Delivery (11 papers). The work is most often cited by research in Pharmaceutical Science (698 citations), Biomaterials (1.3k citations) and Molecular Medicine (247 citations). Patrice Hildgen has collaborated with scholars based in Canada, France and United Kingdom. Frequent co-authors include Jean‐Michel Rabanel, Xavier Banquy, Renu Singh Dhanikula, Grégoire Leclair, Anteneh Argaw, Jean‐François Bouchard, Shilpa Sant, Jean‐Christophe Leroux, Anand Gupta and Suzanne Giasson. Their work appears in journals such as Advanced Materials, Nature Communications and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.